Abbruzzese JL - Search Results

1

Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.

Kopetz S, Hoff PM, Morris JS, Wolff RA, Eng C, Glover KY, Adinin R, Overman MJ, Valero V, Wen S, Lieu C, Yan S, Tran HT, Ellis LM, Abbruzzese JL, Heymach JV. Kopetz S, et al. Among authors: abbruzzese jl. J Clin Oncol. 2010 Jan 20;28(3):453-9. doi: 10.1200/JCO.2009.24.8252. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008624 Free PMC article. Clinical Trial.

2

Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.

Pazdur R, Ajani JJ, Abbruzzese JL, Belt RJ, Dakhil SR, Dubovsky D, Graham S, Pilat S, Winn R, Levin B. Pazdur R, et al. Among authors: abbruzzese jl. Cancer. 1992 Oct 15;70(8):2073-6. doi: 10.1002/1097-0142(19921015)70:8<2073::aid-cncr2820700810>3.0.co;2-a. Cancer. 1992. PMID: 1394037 Clinical Trial.

3

Phase II study of didemnin B in advanced colorectal cancer.

Jones DV Jr, Ajani JA, Blackburn R, Daugherty K, Levin B, Patt YZ, Abbruzzese JL. Jones DV Jr, et al. Among authors: abbruzzese jl. Invest New Drugs. 1992 Aug;10(3):211-3. doi: 10.1007/BF00877248. Invest New Drugs. 1992. PMID: 1428730 Clinical Trial.

4

Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.

Hubbard KP, Pazdur R, Ajani JA, Braud E, Blaustein A, King M, Llenado-Lee M, Winn R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: abbruzzese jl. Am J Clin Oncol. 1992 Dec;15(6):524-7. Am J Clin Oncol. 1992. PMID: 1449117 Clinical Trial.

5

Phase II study of gemcitabine in advanced colorectal adenocarcinoma.

Moore DF Jr, Pazdur R, Daugherty K, Tarassoff P, Abbruzzese JL. Moore DF Jr, et al. Among authors: abbruzzese jl. Invest New Drugs. 1992 Nov;10(4):323-5. doi: 10.1007/BF00944189. Invest New Drugs. 1992. PMID: 1487408 Clinical Trial.

6

Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin.

Raber MN, Faintuch J, Abbruzzese JL, Sumrall C, Frost P. Raber MN, et al. Among authors: abbruzzese jl. Ann Oncol. 1991 Jul;2(7):519-20. doi: 10.1093/oxfordjournals.annonc.a058007. Ann Oncol. 1991. PMID: 1911461 Free article. Clinical Trial.

7

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN, et al. Abbruzzese JL, et al. J Clin Oncol. 1991 Mar;9(3):491-8. doi: 10.1200/JCO.1991.9.3.491. J Clin Oncol. 1991. PMID: 1999720 Clinical Trial.

8

Phase I clinical trial of cisplatin given i.v. with 5-fluorouracil and high-dose folinic acid.

Abbruzzese JL, Amato R, Schmidt S, Raber MN, Frost P. Abbruzzese JL, et al. Cancer Chemother Pharmacol. 1990;26(3):159-62. doi: 10.1007/BF02897192. Cancer Chemother Pharmacol. 1990. PMID: 2357761

9

Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.

Ajani JA, Roth JA, Ryan B, McMurtrey M, Rich TA, Jackson DE, Abbruzzese JL, Levin B, DeCaro L, Mountain C. Ajani JA, et al. Among authors: abbruzzese jl. J Clin Oncol. 1990 Jul;8(7):1231-8. doi: 10.1200/JCO.1990.8.7.1231. J Clin Oncol. 1990. PMID: 2358838

10

Treatment of advanced colorectal cancer.

Abbruzzese JL, Levin B. Abbruzzese JL, et al. Hematol Oncol Clin North Am. 1989 Mar;3(1):135-53. Hematol Oncol Clin North Am. 1989. PMID: 2465291 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters